ANIKET CHAKRABARTI: Open Payments
NPI 1932282936 · PEMBROKE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,045 in 221 payments from 50 companies in 2025. Trend: 2023 $4,719 · 2024 $4,873 · 2025 $5,045
Food & beverage: $5,090
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $545 |
| CeQur Corporation | 1 | $394 |
| PFIZER INC. | 33 | $392 |
| TOLMAR, INC. | 16 | $243 |
| Novo Nordisk Inc | 6 | $217 |
| HARMONY BIOSCIENCES LLC | 2 | $215 |
| ABBVIE INC. | 11 | $178 |
| Aimmune Therapeutics, Inc. | 8 | $176 |
| Lilly USA, LLC | 10 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $161 |
Products named: CeQur Simplicity, AIRSUPRA, JATENZO, WAKIX, FARXIGA, CAPLYTA, NURTEC ODT, NEXLETOL.
Industry payments across MA — which companies pay providers there.
